AI Drug Discovery

AI Drug Discovery

AI Drug Discovery

Building Better Medicines with AI

With 192 compounds and 67 validated assets in cellular models of disease across 12 therapeutic targets for multiple areas of biology, we're innovating at the intersection of data science, biology and drug development

With 192 compounds and 67 validated assets in cellular models of disease across 12 therapeutic targets for multiple areas of biology, we're innovating at the intersection of data science, biology and drug development

Featured In

PartnershipS

Validated by Leading Scientists at Top Academic and Corporate Labs

We recognize that no one business can revolutionize the way medicines are discovered and developed on their own. We want to leverage our technology and expertise in partnership with the world’s leading researchers and scientists.

Publications

Mar 20, 2025

Preprint

AmesNet: A Deep Learning Model Enhancing Generalization in Ames Mutagenicity Prediction

Mar 20, 2025

Preprint

AmesNet: A Deep Learning Model Enhancing Generalization in Ames Mutagenicity Prediction

Mar 20, 2025

Preprint

AmesNet: A Deep Learning Model Enhancing Generalization in Ames Mutagenicity Prediction

Jan 26, 2025

Preprint

Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry

Jan 26, 2025

Preprint

Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry

Jan 26, 2025

Preprint

Demonstrating End-to-End Drug Discovery: GALILEO™ Unlocks Generative AI for Chemistry

Load More

Load More

Load More

Model Medicines

Humanity Can’t Wait Decades, Which is Why We Focus on Days

We are focused on discovering drugs with best-in-class potential against rigorous target product profiles, not merely creating thousands of hits that never reach the clinic.

With GALILEO™, we've discovered 192 compounds and advanced 67 assets in cellular models of disease across 12 therapeutic targets for multiple areas of biology. Our data was validated by preeminent researchers and scientists at premier academic and corporate laboratories.

News & Events

Jun 13, 2025

Announcement

Model Medicines Selected for BARDA VANGUARD: Building the Future of U.S. Health Security

Jun 13, 2025

Announcement

Model Medicines Named to Fierce 15

Apr 2, 2025

Announcement

Model Medicines Advances AI-Driven Drug Safety Prediction with AmesNet™, Achieving Unprecedented Accuracy and Sensitivity in Mutagenicity Testing

Apr 1, 2025

Press

Model Medicines Featured on Bloomberg’s Vanguards of Health Care: Transforming Drug Discovery with AI

Jun 13, 2025

Announcement

Model Medicines Selected for BARDA VANGUARD: Building the Future of U.S. Health Security

Jun 13, 2025

Announcement

Model Medicines Named to Fierce 15

Jun 13, 2025

Announcement

Model Medicines Selected for BARDA VANGUARD: Building the Future of U.S. Health Security

Jun 13, 2025

Announcement

Model Medicines Named to Fierce 15